Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
ACS Nano ; 8(6): 6344-52, 2014 Jun 24.
Article in English | MEDLINE | ID: mdl-24869793

ABSTRACT

A SWCNT/TiO2 nanocomposite ultrathin film that has superhydrophilic and underwater superoleophobic properties after UV-light irradiation is successfully prepared by coating TiO2 via the sol-gel process onto an SWCNT ultrathin network film. The robust and flexible SWCNT/TiO2 nanocomposite films with a thickness and pore size of tens of nanometers can separate both surfactant-free and surfactant-stabilized oil-in-water emulsions in an ultrafast manner with fluxes up to 30 000 L m(-2) h(-1) bar(-1), which is 2 orders of magnitude higher than commercial filtration membranes with similar separation performance, and with high separation efficiency. Most importantly, the films exhibit excellent antifouling and self-cleaning performance during multiple cycles with the aid of the photocatalytic property of TiO2 nanoparticles. This work provides a route for designing ultrathin and superwetting films for effective separation of oil-in-water emulsions. The SWCNT/TiO2 ultrathin film is potentially useful in treating emulsified wastewater produced in industry and daily life and for purification of crude oil and fuel.

2.
Mol Cancer Ther ; 6(8): 2360-70, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17699731

ABSTRACT

Tumors associated with Kaposi's sarcoma-associated herpesvirus infection include Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. Virtually all of the tumor cells in these cancers are latently infected and dependent on the virus for survival. Latent viral proteins maintain the viral genome and are required for tumorigenesis. Current prevention and treatment strategies are limited because they fail to specifically target the latent form of the virus, which can persist for the lifetime of the host. Thus, targeting latent viral proteins may prove to be an important therapeutic modality for existing tumors as well as in tumor prevention by reducing latent virus load. Here, we describe a novel fluorescence-based screening assay to monitor the maintenance of the Kaposi's sarcoma-associated herpesvirus genome in B lymphocyte cell lines and to identify compounds that induce its loss, resulting in tumor cell death.


Subject(s)
Antiviral Agents/pharmacology , Drug Evaluation, Preclinical/methods , Herpesvirus 8, Human/drug effects , Antigens, Viral/metabolism , Biological Assay/methods , Cell Death/drug effects , Fluorescence , Fluorescent Antibody Technique , Humans , Nuclear Proteins/metabolism , Plant Extracts/pharmacology , Reproducibility of Results , Reverse Transcriptase Polymerase Chain Reaction
SELECTION OF CITATIONS
SEARCH DETAIL
...